Thomas Garner

Insider Reports History

Location
Spring, TX
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Garner:

Company Role Class Num Shares Value Price $ Report Date Ownership
ACADIA PHARMACEUTICALS INC EVP, Chief Commercial Officer Restricted Stock Units 45,372 $762,703 $16.81 09 Dec 2024 Direct
LEXICON PHARMACEUTICALS, INC. SVP, Chief Commercial Officer Restricted Stock Units 227,130 $239,236 $1.05 08 Feb 2024 Direct
ACADIA PHARMACEUTICALS INC EVP, Chief Commercial Officer Stock Option (Right to Buy) 235,849 09 Dec 2024 Direct
LEXICON PHARMACEUTICALS, INC. SVP, Chief Commercial Officer Stock Option (Right to Buy) 227,130 08 Feb 2024 Direct

Insider Reports Filed by Thomas Garner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACAD ACADIA PHARMACEUTICALS INC 09 Dec 2024 2 $0 4 EVP, Chief Commercial Officer 10 Dec 2024, 18:33
ACAD ACADIA PHARMACEUTICALS INC 09 Dec 2024 0 $0 3 EVP, Chief Commercial Officer 10 Dec 2024, 18:31
LXRX LEXICON PHARMACEUTICALS, INC. 08 Feb 2024 2 $0 4 SVP, Chief Commercial Officer 12 Feb 2024, 16:14
LXRX LEXICON PHARMACEUTICALS, INC. 09 Oct 2023 1 $0 4 SVP, Chief Commercial Officer 11 Oct 2023, 16:02
LXRX LEXICON PHARMACEUTICALS, INC. 09 Oct 2023 0 $0 3 SVP, Chief Commercial Officer 11 Oct 2023, 16:01